Lv41
714 积分 2024-05-25 加入
Fibrosis: cross-organ biology and pathways to development of innovative drugs
3天前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
7天前
已完结
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
8天前
已完结
FGF-based drug discovery: advances and challenges
13天前
已完结
From lead to market: chemical approaches to transform peptides into therapeutics
13天前
已完结
Computational protein design
25天前
已完结
FGF-based drug discovery: advances and challenges
1个月前
已完结
Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
1个月前
已完结
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity
2个月前
已完结
Development of bispecific T cell engagers: harnessing quantitative systems pharmacology
2个月前
已完结
皖公网安备34019202002308
